These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19624759)

  • 21. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
    Scheibel E; Ingerslev J; Dalsgaard-Nielsen J; Stenbjerg S; Knudsen JB
    Thromb Haemost; 1987 Dec; 58(4):1049-52. PubMed ID: 3127918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab for adolescents with haemophilia and high titre inhibitors.
    Fox RA; Neufeld EJ; Bennett CM
    Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.
    Taylor LD; Dean FL; Tiedemann K; Ekert H
    Thromb Haemost; 1986 Apr; 55(2):158-61. PubMed ID: 3087000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Type A hemophilia in a man undergoing liver resection for metastasis: implications for anesthetic management].
    Fuentes García D; Ramírez Muñoz G
    Rev Esp Anestesiol Reanim; 2009 Mar; 56(3):190-1. PubMed ID: 19408787
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A.
    Stine KC; Becton DL
    Haemophilia; 2006 Jul; 12(4):435-6. PubMed ID: 16834747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of fibrin tissue adhesives in surgery of haemophilia patients.
    Martinowitz U; Varon D; Heim M
    Haemophilia; 1998 Jul; 4(4):443-8. PubMed ID: 9873773
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.
    Martinowitz U; Luboshitz J; Bashari D; Ravid B; Gorina E; Regan L; Stass H; Lubetsky A
    Haemophilia; 2009 May; 15(3):676-85. PubMed ID: 19298381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blunt abdominal trauma with delayed rupture of splenic haematoma in a haemophiliac patient.
    Samaiya A; Gupta S; Chumber S; Kashyap R; Dewanda NK; Vashisht S; Choudhry VP
    Haemophilia; 2001 May; 7(3):331-4. PubMed ID: 11380639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful treatment of hemothorax with recombinant factor VIIa in a hemophilic child with inhibitor].
    Hulíková M; Galajda P; Kubisz P
    Vnitr Lek; 1998 Sep; 44(9):547-50. PubMed ID: 10358467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
    Guérois C; Laurian Y; Rothschild C; Parquet-Gernez A; Duclos AM; Négrier C; Vicariot M; Fimbel B; Fressinaud E; Fiks-Sigaud M
    Thromb Haemost; 1995 Feb; 73(2):215-8. PubMed ID: 7792732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of arteriovenous fistula and brachial artery aneurysm in a patient with mild haemophilia A.
    Wiszniewski A; Szopiński P
    Haemophilia; 2011 May; 17(3):548-50. PubMed ID: 21299738
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
    Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
    Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic rheumatic cardiopathy in a patient with of hemophilia successfully treated with surgery].
    Tarasoutchi F; Grinberg M; Wu TC; Filho CC; Rached RA; Cardoso LF; Pomerantzeff PM; Estevez Filho A; da Luz PL; Bellotti G
    Arq Bras Cardiol; 1994 Nov; 63(5):389-91. PubMed ID: 7611917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous infusion of recombinant factor VIIa: continue or not?
    Ewenstein BM
    Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful surgery in severe haemophilia--a two-stage replacement therapy in resource-poor countries.
    Prabhu R; Jijina F; Shetty S; Ghosh K
    Haemophilia; 2008 Sep; 14(5):1125-6. PubMed ID: 18625030
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
    Bloom AL; Emmanuel JH
    Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
    [No Abstract]   [Full Text] [Related]  

  • 39. Orthotopic liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor from an antithrombin-deficient cadaveric donor.
    Gregg R; Lester W; Bramhall S; Wilde J
    Haemophilia; 2013 Mar; 19(2):e96-7. PubMed ID: 23419109
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous infusion of factor VIII concentrates in obese patients with severe haemophilia A: is weight-based dose-adjustment required?
    Boban A; Henrard S; Lambert C; Hermans C
    Haemophilia; 2016 Jan; 22(1):e62-4. PubMed ID: 26560746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.